CN112137901A - Anti-inflammation hemostasis whitening toothpaste and preparation method thereof - Google Patents
Anti-inflammation hemostasis whitening toothpaste and preparation method thereof Download PDFInfo
- Publication number
- CN112137901A CN112137901A CN202011106879.XA CN202011106879A CN112137901A CN 112137901 A CN112137901 A CN 112137901A CN 202011106879 A CN202011106879 A CN 202011106879A CN 112137901 A CN112137901 A CN 112137901A
- Authority
- CN
- China
- Prior art keywords
- toothpaste
- whitening
- stirring
- silicon dioxide
- type silicon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses an anti-inflammation hemostasis whitening toothpaste and a preparation method thereof, wherein the anti-inflammation hemostasis whitening toothpaste comprises the following raw materials in parts by weight: 8-10% of friction type silicon dioxide, 12-14% of thickening type silicon dioxide, 35-40% of sorbitol, 6-10% of PEG-4006%, 28.36-50% of water, 0.5-1% of sodium carboxymethylcellulose, 0.6-1% of xanthan gum, 0.25-0.8% of saccharin sodium, 122.3-5% of K, 1.2-3% of mint essence, 0.8-2% of ovate leaf holly bark extract, 0.08-5% of tranexamic acid, 0.3-5% of allantoin, 0.1-0.5% of methyl hydroxybenzoate, 0.5-1% of titanium dioxide, 0.01-0.1% of green pigment and 4-10% of sodium phytate. The anti-inflammation hemostasis whitening toothpaste has the effects of treating dental ulcer, whitening, diminishing inflammation hemostasis, reducing internal heat and removing stains, 8-10% of friction type silicon dioxide, thickening type silicon dioxide and ovate leaf holly bark extract are used as main components for whitening, hemostasis, gingival nutrition and repairing, and the mint essence is added into the toothpaste as a component for sterilizing, resisting allergy and removing fishy smell, so that the whitening effect, sterilizing, gingival bleeding, diminishing inflammation, oral cavity damage repairing, halitosis and other oral cavity problems of the toothpaste are obviously improved, and the using effect is improved.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to an anti-inflammation hemostasis whitening toothpaste and a preparation method thereof.
Background
At present, people are eroded by various food residues in a fast paced life all the year round, teeth are gradually yellowed, the toothpaste used by the people for brushing teeth cannot really brush the teeth clean at ordinary times, the teeth are yellow or black and still worry people all the time, the yellow teeth often become smiling handles of the people, a very dirty and sloppy feeling is brought to people, the people are not embarrassed, and the white and white shellfish teeth can enable people to be vivid, have more excellent smile and self-confident, the busy work and the fast paced life enable people not to have more free time to wash teeth in dentistry, and the teeth can be damaged by the frequent washing of the teeth, so that the teeth become sensitive, and the problem of people annoyance is also solved.
In the prior art, the anti-inflammation, hemostasis and whitening toothpaste comprises components such as an abrasive, a cleaning agent, a wetting agent, a preservative, an aromatic and the like in the using process, the whitening principle is only the basic functions of cleaning and corrosion prevention, the cleaning mode is very superficial, the whitening effect is poor, meanwhile, stains which penetrate deep into teeth to a certain depth are not convenient to remove, and the whitening function cannot be really realized.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides an anti-inflammation hemostasis whitening toothpaste and a preparation method thereof, and aims to solve the problems in the background art.
In order to achieve the purpose, the invention provides the following technical scheme: the anti-inflammation hemostasis whitening toothpaste comprises the following raw materials in parts by weight: 8-10% of friction type silicon dioxide, 12-14% of thickening type silicon dioxide, 35-40% of sorbitol, 6-10% of PEG-4006%, 28.36-50% of water, 0.5-1% of sodium carboxymethylcellulose, 0.6-1% of xanthan gum, 0.25-0.8% of saccharin sodium, 122.3-5% of K, 1.2-3% of mint essence, 0.8-2% of ovate leaf holly bark extract, 0.08-5% of tranexamic acid, 0.3-5% of allantoin, 0.1-0.5% of methyl hydroxybenzoate, 0.5-1% of titanium dioxide, 0.01-0.1% of green pigment and 4-10% of sodium phytate.
The preparation method of the anti-inflammation hemostasis whitening toothpaste comprises the following steps:
s1, A-phase water phase treatment: sequentially weighing friction type silicon dioxide, thickening type silicon dioxide, sorbitol, PEG-400, water, sodium carboxymethylcellulose, xanthan gum and saccharin sodium according to parts by weight, putting into a water phase pot, stirring and heating to form a water phase, uniformly stirring, and keeping the temperature for later use;
s2, B phase oil phase treatment: sequentially weighing K12, mint essence, ovate leaf holly bark extract, tranexamic acid and allantoin according to the weight parts, putting the materials into an oil phase pot, stirring and heating the materials to form an oil phase, and preserving heat for later use after uniformly stirring;
s3, emulsification operation; respectively pumping the phase A material stirred in the step S1 and the phase B material stirred in the step S2 into an emulsifying pot by using vacuum, adding methyl hydroxybenzoate, titanium dioxide, green pigment and sodium phytate into the emulsifying pot, starting a homogenizer, carrying out homogenizing operation by using a stirrer, carrying out heat preservation stirring, and then starting cooling treatment for later use;
s4, transparentizing operation: cooling the mixed raw material prepared in the step S3 to 40-50 ℃, uniformly stirring again, and stirring until the mixed raw material is transparent for later use;
s5, cooling and discharging: cooling the mixed raw material obtained in the step S4 to 35 ℃ again, and discharging;
s6, preparing the anti-inflammatory, hemostatic and whitening toothpaste: opening weak homogenization on the mixed raw material discharged in the step S5 to enable the mixed raw material to have fine and smooth appearance to obtain a uniform paste body, and preparing the required toothpaste;
s7, packaging of the anti-inflammatory, hemostatic and whitening toothpaste: and (5) aseptic packaging and warehousing the toothpaste prepared in the step (S6) to finish the preparation of the anti-inflammation hemostasis whitening toothpaste.
Further optimizing the technical scheme, the friction type silicon dioxide and the thickening type silicon dioxide in the step S1 are both silicon dioxide, and the sodium carboxymethyl cellulose in the step S1 is carboxymethyl hydroxyethyl cellulose.
Further optimizing the technical scheme, the K12 in the step S2 is sodium lauryl sulfate, and the mint essence in the step S2 is mint oil.
Further optimizing the technical scheme, the ovateleaf holly bark extract, tranexamic acid and the green pigment in the step S2 are aquilaria sinensis extract, tranexamic acid and green 5 respectively.
Further optimizing the technical scheme, the water phase pot and the oil phase pot in the steps S1 and S2 are both heated to 80-85 ℃, the stirring speed is 30-50r/min, and the heat preservation time is 8-10 min.
Further optimizing the technical scheme, the speed of the stirrer in the step S3 is 60-80r/min, the homogenizing time is 5-8min, and the heat preservation stirring time is 8-10 min.
Further optimizing the technical scheme, the stirring speed in the step S4 is 30-50r/min, and the temperature after cooling in the step S5 is 35-38 ℃.
Compared with the prior art, the invention provides the anti-inflammation hemostasis whitening toothpaste and the preparation method thereof, and the toothpaste has the following beneficial effects:
1. the inflammation-diminishing, bleeding-stopping and whitening toothpaste and the preparation method thereof have the effects of treating dental ulcer, whitening, diminishing inflammation, stopping bleeding, reducing pathogenic fire and removing stains.
2. According to the invention, 8-10% of friction type silicon dioxide, thickening type silicon dioxide and ovate leaf holly bark extract are used as main components for whitening, stopping bleeding, nourishing gum and repairing, and the mint essence is used as a component for sterilizing, resisting allergy and removing fishy smell and is added into the toothpaste, so that the whitening effect, the sterilization, the gingival bleeding, the inflammation diminishing, the oral cavity damage repairing, the halitosis and other oral cavity problems of the toothpaste are obviously improved, and the using effect is improved.
2. The whitening toothpaste prepared by the invention is added with sorbitol, xanthan gum, tranexamic acid and sodium phytate, so that the better activity of the whitening toothpaste is improved, and the whitening toothpaste has better effects of diminishing inflammation and stopping bleeding.
Drawings
Fig. 1 is a flow chart of an anti-inflammatory, hemostatic and whitening toothpaste and a preparation method thereof provided by the invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The first embodiment is as follows:
referring to fig. 1, an anti-inflammatory, hemostatic and whitening toothpaste comprises the following raw materials in parts by weight: 8% of friction type silicon dioxide, 13% of thickening type silicon dioxide, 35% of sorbitol, 8% of PEG-4008%, 30% of water, 0.6% of sodium carboxymethylcellulose, 0.8% of xanthan gum, 0.8% of saccharin sodium, 125% of K, 3% of mint essence, 1% of ovate leaf holly bark extract, 1% of tranexamic acid, 1% of allantoin, 1% of methylparaben, 0.5% of titanium dioxide, 0.02% of green pigment and 5% of sodium phytate.
The preparation method of the anti-inflammation hemostasis whitening toothpaste comprises the following steps:
s1, A-phase water phase treatment: sequentially weighing friction type silicon dioxide, thickening type silicon dioxide, sorbitol, PEG-400, water, sodium carboxymethylcellulose, xanthan gum and saccharin sodium according to parts by weight, putting into a water phase pot, stirring and heating to form a water phase, uniformly stirring, and keeping the temperature for later use;
s2, B phase oil phase treatment: sequentially weighing K12, mint essence, ovate leaf holly bark extract, tranexamic acid and allantoin according to the weight parts, putting the materials into an oil phase pot, stirring and heating the materials to form an oil phase, and preserving heat for later use after uniformly stirring;
s3, emulsification operation; respectively pumping the phase A material stirred in the step S1 and the phase B material stirred in the step S2 into an emulsifying pot by using vacuum, adding methyl hydroxybenzoate, titanium dioxide, green pigment and sodium phytate into the emulsifying pot, starting a homogenizer, carrying out homogenizing operation by using a stirrer, carrying out cooling treatment after heat preservation and stirring for standby, wherein the speed of the stirrer is 60r/min, the homogenizing time is 5min, and the heat preservation and stirring time is 8 min;
s4, transparentizing operation: cooling the mixed raw material prepared in the step S3 to 45 ℃, uniformly stirring again until the mixed raw material is transparent for later use, wherein the stirring speed is 40r/min, and the temperature after cooling in the step S5 is 36 ℃;
s5, cooling and discharging: cooling the mixed raw material obtained in the step S4 to 35 ℃ again, and discharging;
s6, preparing the anti-inflammatory, hemostatic and whitening toothpaste: opening weak homogenization on the mixed raw material discharged in the step S5 to enable the mixed raw material to have fine and smooth appearance to obtain a uniform paste body, and preparing the required toothpaste;
s7, packaging of the anti-inflammatory, hemostatic and whitening toothpaste: and (5) aseptic packaging and warehousing the toothpaste prepared in the step (S6) to finish the preparation of the anti-inflammation hemostasis whitening toothpaste.
As a specific optimization scheme of this embodiment, both the friction-type silica and the thickening-type silica in step S1 are silica, and the sodium carboxymethyl cellulose in step S1 is carboxymethyl hydroxyethyl cellulose.
As a specific optimization scheme of this embodiment, K12 in step S2 is sodium lauryl sulfate, and the mint essence in step S2 is mint oil.
As a specific optimization scheme of this embodiment, the rotundine extract, tranexamic acid and green pigment in step S2 are aquilaria sinensis extract, tranexamic acid and green 5, respectively.
As a specific optimization scheme of the embodiment, the water phase pot and the oil phase pot in the steps S1 and S2 are both heated to 80 ℃, the stirring speed is 40r/min, and the heat preservation time is 8 min.
Example two:
referring to fig. 1, an anti-inflammatory, hemostatic and whitening toothpaste comprises the following raw materials in parts by weight: 8% of friction type silicon dioxide, 12% of thickening type silicon dioxide, 35% of sorbitol, 6% of PEG-4006%, 28.36% of water, 0.5% of sodium carboxymethylcellulose, 0.6% of xanthan gum, 0.25% of saccharin sodium, 122.3% of K, 1.2% of mint essence, 0.8% of ovate bark extract, 0.08% of tranexamic acid, 0.3% of allantoin, 0.1% of methylparaben, 0.5% of titanium dioxide, 0.01% of green pigment and 4% of sodium phytate.
The preparation method of the anti-inflammation hemostasis whitening toothpaste comprises the following steps:
s1, A-phase water phase treatment: sequentially weighing friction type silicon dioxide, thickening type silicon dioxide, sorbitol, PEG-400, water, sodium carboxymethylcellulose, xanthan gum and saccharin sodium according to parts by weight, putting into a water phase pot, stirring and heating to form a water phase, uniformly stirring, and keeping the temperature for later use;
s2, B phase oil phase treatment: sequentially weighing K12, mint essence, ovate leaf holly bark extract, tranexamic acid and allantoin according to the weight parts, putting the materials into an oil phase pot, stirring and heating the materials to form an oil phase, and preserving heat for later use after uniformly stirring;
s3, emulsification operation; respectively pumping the phase A material stirred in the step S1 and the phase B material stirred in the step S2 into an emulsifying pot by using vacuum, adding methyl hydroxybenzoate, titanium dioxide, green pigment and sodium phytate into the emulsifying pot, starting a homogenizer, carrying out homogenizing operation by using a stirrer, carrying out cooling treatment after heat preservation and stirring for standby, wherein the speed of the stirrer is 65r/min, the homogenizing time is 5min, and the heat preservation and stirring time is 8 min;
s4, transparentizing operation: cooling the mixed raw material prepared in the step S3 to 40 ℃, uniformly stirring again until the mixed raw material is transparent for later use, wherein the stirring speed is 30r/min, and the temperature after cooling in the step S5 is 35 ℃;
s5, cooling and discharging: cooling the mixed raw material obtained in the step S4 to 35 ℃ again, and discharging;
s6, preparing the anti-inflammatory, hemostatic and whitening toothpaste: opening weak homogenization on the mixed raw material discharged in the step S5 to enable the mixed raw material to have fine and smooth appearance to obtain a uniform paste body, and preparing the required toothpaste;
s7, packaging of the anti-inflammatory, hemostatic and whitening toothpaste: and (5) aseptic packaging and warehousing the toothpaste prepared in the step (S6) to finish the preparation of the anti-inflammation hemostasis whitening toothpaste.
As a specific optimization scheme of this embodiment, both the friction-type silica and the thickening-type silica in step S1 are silica, and the sodium carboxymethyl cellulose in step S1 is carboxymethyl hydroxyethyl cellulose.
As a specific optimization scheme of this embodiment, K12 in step S2 is sodium lauryl sulfate, and the mint essence in step S2 is mint oil.
As a specific optimization scheme of this embodiment, the rotundine extract, tranexamic acid and green pigment in step S2 are aquilaria sinensis extract, tranexamic acid and green 5, respectively.
As a specific optimization scheme of the embodiment, the water phase pot and the oil phase pot in the steps S1 and S2 are both heated to 80 ℃, the stirring speed is 30r/min, and the heat preservation time is 8 min.
Example three:
referring to fig. 1, an anti-inflammatory, hemostatic and whitening toothpaste comprises the following raw materials in parts by weight: 10% of friction type silicon dioxide, 14% of thickening type silicon dioxide, 40% of sorbitol, 10% of PEG-40010%, 50% of water, 1% of sodium carboxymethylcellulose, 1% of xanthan gum, 0.8% of saccharin sodium, 125% of K, 3% of mint essence, 2% of ovate leaf holly bark extract, 5% of tranexamic acid, 5% of allantoin, 0.5% of methylparaben, 1% of titanium dioxide, 0.1% of green pigment and 10% of sodium phytate.
The preparation method of the anti-inflammation hemostasis whitening toothpaste comprises the following steps:
s1, A-phase water phase treatment: sequentially weighing friction type silicon dioxide, thickening type silicon dioxide, sorbitol, PEG-400, water, sodium carboxymethylcellulose, xanthan gum and saccharin sodium according to parts by weight, putting into a water phase pot, stirring and heating to form a water phase, uniformly stirring, and keeping the temperature for later use;
s2, B phase oil phase treatment: sequentially weighing K12, mint essence, ovate leaf holly bark extract, tranexamic acid and allantoin according to the weight parts, putting the materials into an oil phase pot, stirring and heating the materials to form an oil phase, and preserving heat for later use after uniformly stirring;
s3, emulsification operation; respectively pumping the phase A material stirred in the step S1 and the phase B material stirred in the step S2 into an emulsifying pot by using vacuum, adding methyl hydroxybenzoate, titanium dioxide, green pigment and sodium phytate into the emulsifying pot, starting a homogenizer, carrying out homogenizing operation by using a stirrer, carrying out cooling treatment after heat preservation and stirring for standby, wherein the speed of the stirrer is 80r/min, the homogenizing time is 8min, and the heat preservation and stirring time is 10 min;
s4, transparentizing operation: cooling the mixed raw material prepared in the step S3 to 50 ℃, uniformly stirring again until the mixed raw material is transparent for later use, wherein the stirring speed is 50r/min, and the temperature after cooling in the step S5 is 38 ℃;
s5, cooling and discharging: cooling the mixed raw material obtained in the step S4 to 35 ℃ again, and discharging;
s6, preparing the anti-inflammatory, hemostatic and whitening toothpaste: opening weak homogenization on the mixed raw material discharged in the step S5 to enable the mixed raw material to have fine and smooth appearance to obtain a uniform paste body, and preparing the required toothpaste;
s7, packaging of the anti-inflammatory, hemostatic and whitening toothpaste: and (5) aseptic packaging and warehousing the toothpaste prepared in the step (S6) to finish the preparation of the anti-inflammation hemostasis whitening toothpaste.
As a specific optimization scheme of this embodiment, both the friction-type silica and the thickening-type silica in step S1 are silica, and the sodium carboxymethyl cellulose in step S1 is carboxymethyl hydroxyethyl cellulose.
As a specific optimization scheme of this embodiment, K12 in step S2 is sodium lauryl sulfate, and the mint essence in step S2 is mint oil.
As a specific optimization scheme of this embodiment, the rotundine extract, tranexamic acid and green pigment in step S2 are aquilaria sinensis extract, tranexamic acid and green 5, respectively.
As a specific optimization scheme of the embodiment, the water phase pot and the oil phase pot in the steps S1 and S2 are both heated to 85 ℃, the stirring speed is 50r/min, and the heat preservation time is 10 min.
The invention has the beneficial effects that: according to the invention, 8-10% of friction type silicon dioxide, thickening type silicon dioxide and ovate leaf holly bark extract are used as main components for whitening, stopping bleeding, nourishing gum and repairing, and the mint essence is added into the toothpaste as a component for sterilizing, resisting allergy and removing fishy smell, so that the whitening effect, the sterilization, the gingival bleeding, the inflammation, the oral damage repair, the halitosis and other oral problems of the toothpaste are obviously improved, and the use effect is improved; the pyrithanol, the xanthan gum, the tranexamic acid and the sodium phytate improve the better activity of the inflammation diminishing, bleeding stopping and whitening toothpaste, and have better inflammation diminishing, bleeding stopping and whitening effects.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (8)
1. The anti-inflammation, bleeding stopping and whitening toothpaste is characterized by comprising the following raw materials in parts by weight: 8-10% of friction type silicon dioxide, 12-14% of thickening type silicon dioxide, 35-40% of sorbitol, 6-10% of PEG-4006%, 28.36-50% of water, 0.5-1% of sodium carboxymethylcellulose, 0.6-1% of xanthan gum, 0.25-0.8% of saccharin sodium, 122.3-5% of K, 1.2-3% of mint essence, 0.8-2% of ovate leaf holly bark extract, 0.08-5% of tranexamic acid, 0.3-5% of allantoin, 0.1-0.5% of methyl hydroxybenzoate, 0.5-1% of titanium dioxide, 0.01-0.1% of green pigment and 4-10% of sodium phytate.
2. The preparation method of the anti-inflammation hemostasis whitening toothpaste is characterized by comprising the following steps:
s1, A-phase water phase treatment: sequentially weighing friction type silicon dioxide, thickening type silicon dioxide, sorbitol, PEG-400, water, sodium carboxymethylcellulose, xanthan gum and saccharin sodium according to parts by weight, putting into a water phase pot, stirring and heating to form a water phase, uniformly stirring, and keeping the temperature for later use;
s2, B phase oil phase treatment: sequentially weighing K12, mint essence, ovate leaf holly bark extract, tranexamic acid and allantoin according to the weight parts, putting the materials into an oil phase pot, stirring and heating the materials to form an oil phase, and preserving heat for later use after uniformly stirring;
s3, emulsification operation; respectively pumping the phase A material stirred in the step S1 and the phase B material stirred in the step S2 into an emulsifying pot by using vacuum, adding methyl hydroxybenzoate, titanium dioxide, green pigment and sodium phytate into the emulsifying pot, starting a homogenizer, carrying out homogenizing operation by using a stirrer, carrying out heat preservation stirring, and then starting cooling treatment for later use;
s4, transparentizing operation: cooling the mixed raw material prepared in the step S3 to 40-50 ℃, uniformly stirring again, and stirring until the mixed raw material is transparent for later use;
s5, cooling and discharging: cooling the mixed raw material obtained in the step S4 to 35 ℃ again, and discharging;
s6, preparing the anti-inflammatory, hemostatic and whitening toothpaste: opening weak homogenization on the mixed raw material discharged in the step S5 to enable the mixed raw material to have fine and smooth appearance to obtain a uniform paste body, and preparing the required toothpaste;
s7, packaging of the anti-inflammatory, hemostatic and whitening toothpaste: and (5) aseptic packaging and warehousing the toothpaste prepared in the step (S6) to finish the preparation of the anti-inflammation hemostasis whitening toothpaste.
3. The method for preparing an anti-inflammatory, hemostatic and whitening toothpaste according to claim 2, wherein the friction type silica and the thickening type silica in step S1 are both silica, and the sodium carboxymethyl cellulose in step S1 is carboxymethyl hydroxyethyl cellulose.
4. The method for preparing an anti-inflammatory, hemostatic and whitening toothpaste according to claim 2, wherein the K12 in step S2 is sodium lauryl sulfate, and the mint essence in step S2 is peppermint oil.
5. The method for preparing anti-inflammatory, hemostatic and whitening toothpaste according to claim 2, wherein the cortex Ilicis Rotundae extract, tranexamic acid and green pigment in step S2 are Aquilaria sinensis extract, tranexamic acid and Green 5 respectively.
6. The method for preparing toothpaste with antiinflammatory, hemostatic and whitening effects according to claim 2, wherein the water phase pot and the oil phase pot in steps S1 and S2 are heated to 80-85 ℃, the stirring speed is 30-50r/min, and the heat preservation time is 8-10 min.
7. The method for preparing toothpaste with anti-inflammatory, hemostatic and whitening effects according to claim 2, wherein the stirrer speed in step S3 is 60-80r/min, the homogenizing time is 5-8min, and the stirring time is 8-10 min.
8. The method for preparing toothpaste with anti-inflammatory, hemostatic and whitening effects according to claim 2, wherein the stirring speed of step S4 is 30-50r/min, and the temperature after cooling in step S5 is 35-38 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011106879.XA CN112137901A (en) | 2020-10-16 | 2020-10-16 | Anti-inflammation hemostasis whitening toothpaste and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011106879.XA CN112137901A (en) | 2020-10-16 | 2020-10-16 | Anti-inflammation hemostasis whitening toothpaste and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112137901A true CN112137901A (en) | 2020-12-29 |
Family
ID=73952205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011106879.XA Pending CN112137901A (en) | 2020-10-16 | 2020-10-16 | Anti-inflammation hemostasis whitening toothpaste and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112137901A (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003089627A (en) * | 2001-09-19 | 2003-03-28 | Lion Corp | Toothpaste agent composition |
| US20030124069A1 (en) * | 2001-11-08 | 2003-07-03 | J.M. Huber Corporation | Composite abrasive material for oral compositions, and methods of making and using same |
| CN103417393A (en) * | 2013-08-02 | 2013-12-04 | 杭州皎洁口腔保健用品有限公司 | Enhanced stain-removing toothpaste and preparation method thereof |
| CN104013547A (en) * | 2014-05-26 | 2014-09-03 | 皖南医学院 | Toothpaste for stopping bleeding, brightening and refreshing breath and preparation method thereof |
| CN106109330A (en) * | 2016-08-03 | 2016-11-16 | 何建军 | Long-acting care toothpaste combination and preparation method thereof after a kind of toothwash |
| CN108014055A (en) * | 2018-02-05 | 2018-05-11 | 广州市倩采化妆品有限公司 | A kind of Lignum Aquilariae Resinatum extract and the plant multiple-effect type toothpaste of licorice compounding |
| CN108524374A (en) * | 2018-06-28 | 2018-09-14 | 广东南方洁灵科技实业有限公司 | It is a kind of for the toothpaste and its manufacturing method of a variety of oral problems and application |
| CN109276475A (en) * | 2018-11-20 | 2019-01-29 | 湖北中医药大学 | One kind Chinese medicinal toothpaste containing bletilla polysaccharide and preparation method thereof |
-
2020
- 2020-10-16 CN CN202011106879.XA patent/CN112137901A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003089627A (en) * | 2001-09-19 | 2003-03-28 | Lion Corp | Toothpaste agent composition |
| US20030124069A1 (en) * | 2001-11-08 | 2003-07-03 | J.M. Huber Corporation | Composite abrasive material for oral compositions, and methods of making and using same |
| CN103417393A (en) * | 2013-08-02 | 2013-12-04 | 杭州皎洁口腔保健用品有限公司 | Enhanced stain-removing toothpaste and preparation method thereof |
| CN104013547A (en) * | 2014-05-26 | 2014-09-03 | 皖南医学院 | Toothpaste for stopping bleeding, brightening and refreshing breath and preparation method thereof |
| CN106109330A (en) * | 2016-08-03 | 2016-11-16 | 何建军 | Long-acting care toothpaste combination and preparation method thereof after a kind of toothwash |
| CN108014055A (en) * | 2018-02-05 | 2018-05-11 | 广州市倩采化妆品有限公司 | A kind of Lignum Aquilariae Resinatum extract and the plant multiple-effect type toothpaste of licorice compounding |
| CN108524374A (en) * | 2018-06-28 | 2018-09-14 | 广东南方洁灵科技实业有限公司 | It is a kind of for the toothpaste and its manufacturing method of a variety of oral problems and application |
| CN109276475A (en) * | 2018-11-20 | 2019-01-29 | 湖北中医药大学 | One kind Chinese medicinal toothpaste containing bletilla polysaccharide and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2184522C2 (en) | Composition containing delustrant or pearl dye and at least one fatty alcohol | |
| CN106389235A (en) | Toothpaste with breath freshening and whitening functions and manufacturing technology thereof | |
| CN106176546A (en) | Based on the cleaning of the chitosan derivatives degree of depth, bacteriostatic tooth protective collutory and preparation method thereof | |
| CN112120980A (en) | Foundation-strengthening and vitality-reinforcing shampoo and preparation method thereof | |
| CN105250205A (en) | Traditional Chinese medicine antibacterial toothpaste and preparation method thereof | |
| CA1052275A (en) | Shampoo compositions with hair conditioning properties | |
| CN105326708A (en) | Notoginseng whitening toothpaste | |
| CN112137901A (en) | Anti-inflammation hemostasis whitening toothpaste and preparation method thereof | |
| CN105534731B (en) | A kind of still based on polyion water removes peculiar smell hand cleanser and preparation method thereof | |
| KR101661511B1 (en) | Hair processing agent and method for perming or dying hair using the same | |
| CN112120978A (en) | Nourishing and repairing shampoo and preparation method thereof | |
| CN115813799A (en) | Whitening and tooth-protecting composition and application thereof in oral care products | |
| JP5144040B2 (en) | Hair treatment composition | |
| CN112494393A (en) | Shampoo and preparation method thereof | |
| CN113143779A (en) | Anhydrous whitening toothpaste containing baking soda and perlite | |
| CN112120959A (en) | Acne-removing skin-tendering whitening essence and preparation method thereof | |
| CN108929809A (en) | A kind of formula and preparation method thereof of blueberry whitening spot-removing perfumed soap | |
| CN110169931A (en) | A kind of halite toothpaste and preparation method thereof | |
| CN110538125A (en) | Plant whitening facial cleanser and preparation method thereof | |
| CN115364016B (en) | Toothpaste with periodontal disease improving effect and preparation method thereof | |
| CN109106635A (en) | Draft essence composition, shampoo and preparation method thereof | |
| CN101181192A (en) | Toothpaste for removing dental calculi | |
| JP2005179225A (en) | Hair dye composition | |
| CN115581628A (en) | Fresh mouthwash formula process | |
| CN115105426A (en) | Preparation method of tooth whitening preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201229 |
|
| RJ01 | Rejection of invention patent application after publication |